CLINICAL GUIDELINES OF RUSSIAN RESPIRATORY SOCIETY: ALGORITHM FOR THE MANAGEMENT OF PATIENTS WITH COPD


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

By the end of 2016, Expert council of the Russian respiratory society has prepared a new edition of the Federal clinical guidelines, and algorithm of management of patient with established COPD diagnosis became an important its part. This algorithm reflects the current views of the differentiated approach to the management of patients with COPD. In recent years, the effectiveness of a number of new drugs and their combinations, as well as a fundamentally new class of biological molecules for the treatment of COPD has been intensively studied. In the near future, aff of this wiff certainly have an impact on our current ideas about the differentiated approach to the treatment and open up new opportunities for more individualized treatment of patients with COPD.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Sergey AVDEEV

Email: pulmo_fmba@mail.ru
corresponding member of RAS, MD, professor deputy director Scientific research institute of pulmonology 105077, Moscow, 32 11th Parkovaya St

Zaurbek AYSANOV

MD, professor, Department of pulmonology, Faculty of additional professional education, N.I. Pirogov Russian national research medical university 105077, Moscow, 32 11th Parkovaya St

Andrey BELEVSKY

MD, professor, head of the Department of pulmonology, Faculty of additional professional education, N.I. Pirogov Russian national research medical university 105077, Moscow, 32 11th Parkovaya St

Әдебиет тізімі

  1. Хроническая обструктивная болезнь легких. Клинические рекомендации. 2016. 69 с. http://spulmo.ru/obrazovatelnye-resursy/ federalnye-klinicheskie-rekomendatsii/ [Chronic obstructive pulmonary disease. Clinical guidelines. 2016. 69 p. (in Russ.)]
  2. Требования к оформлению клинических рекомендаций для размещения в Рубрикаторе. Министерство здравоохранения РФ. М., 2016. 18 с. [Requirements for registration of clinical recommendations for placement in the Categories. Ministry of healthcare of the Russian Federation. Moscow, 2016. 18 p. (in Russ.)]
  3. Jones P.W., Brusselle G., Dal Negro R.W., Ferrer M., Kardos P., Levy M.L., Perez T., Soler Cataluna J.J., van der Molen T., Adamek L., Banik N. Patient-centered assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe. Prim. Care Respir. J. 2012;21(3):329-36.
  4. White P., Thorntoh H., Pinnock H., Georgopoulou S., Booth H.P. Overtreatment of COPD with inhaled corticosteroids - implications for safety and costs: cross-sectional observational study. PLoS ONE. 2013;8:e75221.
  5. Rossi A., Guerriero M., Corrado A. OPTIMO/AIPO Study Group. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO). Respir. Res. 2014;15:77.
  6. Magnussen H., Disse B., Rodriguez-Roisin R., Kirsten A., Watz H., Tetzlaff K., Towse L., Finnigan H., Dahl R., Decramer M., Chanez P., Wouters E.F., Calverley P.M. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N. Engl. J. Med. 2014;371(14):1285-94.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>